Pfizer expands to multiple myeloma with FDA approval

The latest stories trending on MedCity News.

Editor's Pick

Top Story Pfizer Expands to Multiple Myeloma With FDA Approval for New Antibody Drug Oncology is already a big piece of Pfizer's drug lineup. The portfolio is expanding to multiple myeloma with FDA approval of Elrexfio, a bispecific antibody that targets the cancer protein BCMA. Sponsored Content How To Improve Poor Data Quality Across the Healthcare Ecosystem and Make Workflows More Manageable Presented by IMO Health and MedCity News Join us on August 24th as we will explore the impact of poor data quality and methods to improve patient data quality. It will also highlight healthcare industry employee burnout and how to improve retention. Sign up here today! Check Out the Startup Contestants at INVEST Digital Health These six FemTech startups will compete in the Pitch Perfect contest on October 26th in Dallas at Pegasus Park for a chance to win the grand prize. Don't miss your opportunity to check out these female health innovators, connect, develop partnerships and so much more. Hurry and you can still save $150 until 8/25. Reserve My Seat Now

Featured News

Drug Shortages Not Only Exacerbate Healthcare Burnout But Can Also Harm Patient Care The second quarter of 2023 ended with 309 active drug shortages, the highest total in nearly a decade, according to a new report from ASHP. One of the organization's executives pointed out that drug shortages have two major impacts on health systems: they create a lot of extra work for the pharmacy department, and they force clinicians to make tough decisions about patient care that could potentially result in worse patient outcomes. Gilead Partners With Startup Getting Its Tentacles Into New Biologic Drug Territory Gilead Sciences is partnering with Tentarix Biotherapeutics, a startup developing multifunctional antibody drugs that it calls "Tentacles." Tentarix's technology offers the potential to selectively address targets in cancer and inflammation. Evernorth: 3 Actionable Insights To Help Health Plans Improve Cancer Care Immune checkpoint inhibitors are effective cancer treatments, but are expensive. Understanding the least-costly settings for administering treatments, leveraging genomic testing and following evidence-based guidelines can help health plans optimize cancer care, according to Evernorth Research Institute. 43K Patients in California Could Get Refunds, Bill Corrections As Part of Discounted Care Settlement Santa Clara Valley Healthcare in California has begun notifying 43,000 patients about their eligibility for billing corrections and refunds. The system's patient outreach effort is a result of a recently settled lawsuit filed against Santa Clara County. In the complaint, former patients alleged the county did not inform them about its hospitals' charity care and discount payment policies, leading them to have to pay large bills. MedArrive, Heartbeat Health Team Up To Offer In-home Cardio Care In-home provider MedArrive can now connect members of its payer customers, particularly Medicaid plans, to Heartbeat Health for virtual cardiovascular services, the companies announced Tuesday. Fine-Tuning, Prompt Engineering are Keys to Delivering Real Generative AI Solutions to Commercial Pharma Operations Today Generative AI further enhances the value of prompt engineering by synthesizing important insights from various interactions, including text, images, compliant transcripts, and call notes. By automating this process, generative AI quickly transforms on-the-ground insights into robust analytics.

Resources

How AI Helps Health Systems Improve the Quality of Care for Patients with Chronic Conditions Discover how to utilize AI to proactively target patients at risk of chronic conditions and improve health outcomes. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe